An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS-Reference-Cited by-同舟云学术

An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS

Published:2011-08-17 Issue:10 Volume:2 Page:741-746
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Calderón Félix¹,Barros David¹,Bueno José María¹,Coterón José Miguel¹,Fernández Esther¹,Gamo Francisco Javier¹,Lavandera José Luís¹,León María Luisa¹,Macdonald Simon J. F.²,Mallo Araceli¹,Manzano Pilar¹,Porras Esther¹,Fiandor José María¹,Castro Julia¹

Affiliation:

1. Tres Cantos Medicines Development Campus, DDW, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Spain

2. Medicines for Malaria Venture (MMV), 20, route de Pré-Bois-PO Box 1826, 1215 Geneva 15, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml200135p

Reference17 articles.

1. Malaria: progress, perils, and prospects for eradication

2. World Health Organization. World malaria report; http://www.who.int/malaria/publications/atoz/9789241563901/en/index.htmlæ, 2009.

3. The pathophysiology of vivax malaria

4. Public – private 'partnerships' in health – a global call to action

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Biological Evaluation of 4-Thiazolidinone Scaffold: A Versatile Chemistry and Diverse Biological Applications in the Drug Discovery and Development;S-Heterocycles;2024

2. Rational Design and Lead Optimisation of Potent Antimalarial Quinazolinediones and Their Cytotoxicity against MCF-7;Molecules;2023-03-28

3. Proton tautomerism and stereoisomerism of 4-amino-1,3-thiazol-2(5H)-one derivatives bearing substituents with opposite electronic effects: Synthesis, structure and spectroscopic studies;Journal of Molecular Structure;2023-02

4. New targets for antimalarial drug discovery;Current Opinion in Microbiology;2022-12

5. Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362;Journal of Medicinal Chemistry;2022-10-10